Medication review conducted collaboratively by pharmacists and general medical practitioners (GPs) is a widely researched strategy to optimise medication use [1–3].Home Medicines Review (HMR) is an Australian government funded collaborative medication review service for people living independently in the community. This service has traditionally involved a GP referring a patient to their preferred community pharmacy, which in turn arranges a pharmacist to conduct the review. In October 2011, an additional referral pathway was introduced. Rather than referring to a community pharmacy, GPs may now refer directly to an HMR accredited pharmacist. In this issue, Freeman et al.  describe an innovative practice model, consistent with this new referral pathway, in which an accredited ‘practice-pharmacist’ works in a GP medical practice.